SCHEMBL19685084

SCHEMBL19685084

Cc1sc(Nc2cc(F)cc(F)c2)nc1C(=O)NC1CCC12CCC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC3 Q13507 4/20 0.35
▸ TRPC6 Q9Y210 4/20 0.35
▸ TRPA1 O75762 1/20 0.35
▸ CACNA1C Q13936 1/20 0.35
▸ SCN5A Q14524 1/20 0.35
▸ TRPV1 Q8NER1 1/20 0.35
▸ TRPV4 Q9HBA0 1/20 0.35
▸ TNIK Q9UKE5 2/20 0.35
▸ DHODH Q02127 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HCRTR1 O43613 2/20 0.31
▸ HDAC3 O15379 2/20 0.31
▸ HDAC1 Q13547 2/20 0.31
▸ HDAC2 Q92769 2/20 0.31
▸ HDAC6 Q9UBN7 2/20 0.31
▸ PARP14 Q460N5 2/20 0.31
▸ CACNA1H O95180 1/20 0.31
▸ SYK P43405 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31438371 1.00 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438348 0.98 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438354 0.98 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL19685092 0.98 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438406 0.92 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438409 0.92 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL21522981 0.90 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438347 0.90 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438379 0.90 TRPC3 (0.35) TRPC3TRPC6TRPA1CACNA1CSCN5A
SCHEMBL31438386 0.88 TNIK (0.36) TRPC3TRPC6TRPA1CACNA1CSCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109195966-B Microbiocidal thiazole derivatives 先正达参股股份有限公司 2022-09-16 — — CN disclosed
EP-3464284-B1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-10-21 — — EP disclosed
EP-3464284-B1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-10-21 — — EP disclosed
US-10662182-B2 Microbiocidal thiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-05-26 — — US disclosed
US-10662182-B2 Microbiocidal thiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-05-26 — — US disclosed
US-20190330168-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-10-31 — — US disclosed
US-20190330168-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-10-31 — — US disclosed
WO-2017207362-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-12-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190330168-A1 MICROBIOCIDAL THIAZOLE DERIVATIVES MSR1, CASP1, MPO TRPC3 874/4885TRPC6 1900/4885TRPA1 49/4885
US-10662182-B2 Microbiocidal thiazole derivatives MSR1, CASP1, MPO TRPC3 874/4885TRPC6 1900/4885TRPA1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback